Last Updated : December 14, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.
nitisinone
| Brand name | Generic name | Manufacturer | Indication(s) |
| Nitisinone | nitisinone | Cycle Pharmaceuticals Ltd. | Hereditary tyrosinemia type 1 |
| Project Number | Call for patient input | Patient input deadline | Submit patient input |
| SR0554-000 | 2017-12-14 | 2018-02-09 | Submit |
pegfilgrastim
| Brand name | Generic name | Manufacturer | Indication(s) |
| Lapelga | pegfilgrastim | Apobiologix | Febrile neutropenia, prevention or treatment |
| Project Number | Call for patient input | Patient input deadline | Submit patient input |
| SE0555-000 | 2017-12-14 | 2018-02-09 | Submit |
ozenoxacin
| Brand name | Generic name | Manufacturer | Indication(s) |
| Ozanex | ozenoxacin | Cipher Pharmaceuticals Inc. | Impetigo |
| Project Number | Call for patient input | Patient input deadline | Submit patient input |
| SR0553-000 | 2017-12-14 | 2018-02-09 | Submit |
Last Updated : December 14, 2017